Drug Database
PA

pancrelipase (Ultrase MT20 / Ultrase MT / Ultresa)

✓ Approved

Adare Pharma Solutions · PNLIP

What is pancrelipase?

pancrelipase is a therapeutic agent developed by Adare Pharma Solutions. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesUltrase MT20, Ultrase MT, Ultresa
CompanyAdare Pharma Solutions
Molecular TargetPNLIP
RouteOral (PO)
StatusApproved

Mechanism of Action

Molecular Targets

pancrelipase acts on 1 molecular target:

PNLIPpancreatic lipase (PL, PNLIPD)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

pancrelipase is developed for 3 unique indications across 2 therapeutic areas.

Therapeutic AreaConditionPhase
InvestigationsFaecal fat increased✓ Approved
Gastrointestinal disordersSteatorrhoea✓ Approved
Gastrointestinal disordersPancreatic failure✓ Approved

Related Research Articles

PubMedCommunications biology2026-10-15

An ALLO-1-associated network links mitochondrial quality control to functional recovery in structurally compromised muscle.

Sarkar Anwesha A, Biriczová Lilla L, Szulc Natalia A NA, Thapa Pankaj P et al.

Muscle function can recover before damaged contractile structures are fully repaired, but the mechanisms enabling this recovery remain poorly understood. Using a temperature-sensitive Caenorhabditis elegans model of UNC-45 dysfunction, in which impaired myosin chaperoning triggers muscle proteotoxic stress and reversible paralysis, we show that coordinated movement recovers while sarcomere disorganisation persists. Quantitative proteomics identified ALLO-1, a selective-autophagy receptor previously characterised for paternal organelle clearance during embryogenesis, as induced during recovery from UNC-45dependent muscle stress. Functional and proteomic analyses revealed an ALLO-1-associated regulatory network comprising IKKE-1, SIP-1, DIM-1 and CAR-1 that modulates mitochondrial stress responses and muscle recovery. Loss of ALLO-1 or its associated factors altered mitochondrial homoeostasis and delayed functional recovery, whereas muscle-specific ALLO-1a restoration improved recovery, preserved mitochondrial network integrity, and modulated mitochondrial turnover despite reduced respiratory capacity. These findings identify ALLO-1 as a regulator of mitochondrial stress adaptation that enables functional recovery before completing structural repair.

PubMedJournal of cell science2026-10-15

Pharmacological inhibition of MCL-1 disrupts mitochondrial cristae and depletes the human neural progenitor cell pool.

Hanna Marina R MR, Costanzo James J, Yarbrough Madison M, Gil Melanie M et al.

Myeloid cell leukemia 1 (MCL-1) is a canonical anti-apoptotic protein crucial for early neurodevelopment. Loss of MCL-1 results in embryonic-lethal neurodevelopmental defects that cannot be rescued by other anti-apoptotic proteins of the B cell lymphoma 2 (BCL-2) family. Here, we pharmacologically inhibit MCL-1 in human neural progenitor cells and find non-apoptotic roles for MCL-1 in sustaining mitochondrial cristae integrity, fatty acid oxidation and neural progenitor identity. MCL-1 inhibition disrupts mitochondrial ultrastructure, leading to a swollen network with disorganized cristae and destabilized OPA1-MICOS machinery that fails to maintain inner mitochondrial membrane architecture. These structural defects are accompanied by displacement of ACSL1 from the outer mitochondrial membrane, impaired fatty acid oxidation, lipid droplet accumulation and reduced mitochondrial oxygen consumption, revealing a tight link between cristae architecture and metabolic competence. Mechanistically, MCL-1 acts through two coordinated functions: maintaining cristae integrity at the inner mitochondrial membrane and retaining ACSL1 at the outer mitochondrial membrane, both independently of caspase activation. Functionally, MCL-1 inhibition selectively depletes intermediate progenitor cells without affecting proliferation, indicating a direct role in lineage progression. Together, our findings position MCL-1 upstream of OPA1, MICOS and ACSL1, and identify it as a critical coordinator of cristae organization, lipid metabolism and neural progenitor fate. This establishes mitochondrial inner membrane architecture as an instructive determinant of human neurogenesis and highlights non-canonical MCL-1 functions as critical regulators of human brain development.

PubMedAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026-10-15

Loss of Intestinal MSTN Promotes GLP-1 Secretion Through SGLT1 Palmitoylation.

Han Sheng-Zhong SZ, Chang Shuang-Yan SY, Luo Zhaobo Z, Sun Ke K et al.

Intestinal glucagon-like peptide-1 (GLP-1) is secreted by intestinal L cells in a glucose-dependent manner. The localization and surface abundance of glucose-sensing proteins on the cell membrane affect the response to glucose, but the regulatory mechanism remains poorly understood. Here, we show that S-palmitoylation is required for stable plasma membrane enrichment of SGLT1 and for SGLT1-mediated GLP-1 secretion. Notably, myostatin (MSTN) was identified as a key upstream regulator of this modification. Intestinal MSTN deficiency markedly enhanced SGLT1 palmitoylation, increased its plasma membrane abundance, and thereby promoted glucose-stimulated GLP-1 secretion. Importantly, simvastatin induced intestinal MSTN upregulation and impaired glucose homeostasis, whereas MSTN deficiency largely alleviated these effects. Mechanistically, MSTN regulated the expression of the palmitoyl acyltransferase ZDHHC20, which catalyzed SGLT1 S-palmitoylation at Cys301. Blocking SGLT1 palmitoylation attenuated SGLT1 membrane enrichment and markedly suppressed the induction of GLP-1 secretion caused by MSTN deficiency. Collectively, our research results have revealed a new mechanism by which MSTN regulates intestinal endocrine function and S-palmitoylation modification promotes GLP-1 secretion, providing potential targets for regulating endogenous GLP-1 secretion in the intestine and treating metabolic diseases related to glucose imbalance.

PubMedHaematologica2026-10-15

Cord blood-derived natural killer cells engineered with a novel, highaffinity chimeric antigen receptor can eliminate acute myeloid leukemia cells with minimal C-type lectin-like molecule-1 expression.

Suga Makiko M, Kida Shuhei S, Mizutani Yo Y, Kogue Yosuke Y et al.

CAR NK cell therapy is expected to be developed to treat acute myeloid leukemia (AML). C-type lectin-like molecule 1 (CLL-1) is a candidate target. However, AML cells with minimal CLL-1 expression (CLL-1dim) may not be eliminated by CAR NK cells. Here we demonstrate that cord blood (CB)-derived NK cells transduced with a novel high-affinity CAR that recognizes CLL-1 can eliminate CLL-1dim AML cells. A newly established anti- CLL-1 monoclonal antibody (mAb) designated as 2-23 exhibits a higher affinity for CLL- 1 than the widely used anti-CLL-1 mAb M26. CB-derived NK cells transduced with a CAR derived from 2-23, but not M26, killed CLL-1dim AML cells in vitro. Additionally, treatment with 2-23 CAR NK cells, but not M26 CAR NK cells, significantly enhanced the survival of the mice transplanted with CLL-1dim AML cells in vivo. Furthermore, in AML patient-derived xenograft models, the 2-23 CAR NK cells expanded robustly, persisted, and eradicated AML cells.

PubMedEMBO reports2026-10-15

C. elegans GPCR kinase GRK-1 maintains behavioral persistence in a dynamic thermal environment.

Huang Tzu-Ting TT, Nakano Shunji S, Lukova Maria M, Matsuyama Hironori J HJ et al.

How do animals maintain behavioral states as sensory inputs vary with movement and location? Here, we uncover a neuronal mechanism that allows the nematode Caenorhabditis elegans to move isothermally on a temperature gradient for several minutes at temperatures associated with its food experience. We find that prolonged isothermal tracking along the preferred temperature requires GRK-1, the C. elegans homolog of human GPCR kinase GRK5. Loss of grk-1 reduces isothermal tracking durations, and these defects can be rescued by simultaneous grk-1 expression in RIM and AVA interneurons. Furthermore, silencing RIM and AVA restores the short isothermal tracking defects in the absence of grk-1, while leaving wild-type isothermal tracking unchanged. These data suggest that wild-type RIM and AVA are in a suppressed neuronal state during isothermal tracking. Also, imposing a normally suppressed neuronal state in RIM and AVA during isothermal tracking can functionally compensate for the loss of grk-1. Together, our findings reveal a previously unknown molecule-to-circuit function of GRK-1/GRK5 in RIM and AVA interneurons that maintains a minute-scale behavioral state on a temperature gradient.

PubMedCurrent microbiology2026-10-15

Diversity and Functional Screening of Trichoderma Species from Soils in Nanchang, China.

Qiu Yanan Y, Fan Lili L, Fu Kehe K, Xiong Min M et al.

A total of 111 Trichoderma isolates were obtained from soil samples collected in Nanchang, China. Based on morphological characteristics and molecular phylogenetic analysis of the translation elongation factor 1-alpha (tef1) gene, these isolates were assigned to 16 distinct phylogenetic lineages closely related to known species, with T. semiorbis, T. asperellum, and T. koningiopsis being the most predominant, accounting for 29, 22, and 16 isolates, respectively. All isolates were functionally screened for the production of five industrially relevant enzymes (laccase, xylanase, cellulase, chitinase, and amylase) and for copper tolerance. Several strains exhibited remarkable enzymatic activities: T. asperellum TasJK96 demonstrated the highest phenol oxidase activity (1.95 ± 0.12 U·mL- 1), T. virens TviJK51 excelled in xylanase production (41.49 ± 1.02 U·mL- 1), T. afroharzianum Tafxt15 exhibited the highest cellulase activity (22.56 ± 0.70 U·mL- 1), T. lentinulae TleJK44 was the top chitinase producer (22.21 ± 0.83 U·mL- 1), and T. koningiopsis TkoJK88 demonstrated the highest amylase activity (91.26 ± 2.25 U·mL- 1). Furthermore, 13 isolates displayed tolerance to copper, with T. virens TviJK10 exhibiting growth at concentrations up to 4.90 mmol·L- 1. This study expands our understanding of Trichoderma diversity in the Nanchang region and provides a collection of promising candidate strains for future biotechnological and bioremediation applications.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about pancrelipase